Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBL 2018 for children and adolescents with lymphoblastic lymphoma
2017-001691-39Phase 3Active
- Sponsor
- Universitätsklinikum Münster
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone, prednisone, pegaspargase and methotrexate in lymphoblastic lymphoma (LL) (4 arms), sponsored by Universitätsklinikum Münster. Started Dec 2018; status: active.
02
Drugs
dexamethasoneprednisonepegaspargasemethotrexate
03
Conditions
lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on 2017-001691-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001691-39.